Claims
- 1. A compound of the formula: ##STR17## wherein (A) p is the integer 0 or 1;
- (B) R.sub.1 represents one or more substituents of the aromatic ring which may be the same or different and is selected from the group consisting of:
- (i) C.sub.1 -C.sub.25 alkyl, C.sub.2 -C.sub.25 alkenyl, C.sub.1 -C.sub.25 alkoxy, C.sub.1 -C.sub.25 thioalkyl, C.sub.2 -C.sub.25 alkenyloxy, phenyl, phenoxy, substituted phenyl and substituted phenoxy wherein the substituents are selected from the group consisting of C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 alkoxy, halogen and trifluoromethyl;
- (ii) hydrogen, halogen, trifluoromethyl, cyano and nitro;
- (iii) --CO.sub.2 R.sub.4, --CONHR.sub.3, --CHO, OCONHR.sub.4, and --NHCOR.sub.4 wherein R.sub.3 is selected from the group consisting of C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and C.sub.1 -C.sub.4 alkylamino, and R.sub.4 is selected from the group consisting of C.sub.1 -C.sub.25 alkyl, C.sub.2 -C.sub.25 alkenyl, phenyl and substituted phenyl wherein the substituents are selected from the group consisting of C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 alkoxy, halogen and trifluoromethyl;
- C) the moiety R.sub.2 represents one or more substituents of the aromatic ring which may be in any position and are selected from the group consisting of hydrogen, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy and halogen; and
- (D) Y represents a moiety selected from those of the formulae: ##STR18## wherein the moiety R.sub.5 is one or more substituents of the heterocyclic ring which may be the same or different and are selected from the group consisting of hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 acyl or C.sub.1 -C.sub.6 alkoxy, R.sub.6 is C.sub.1 -C.sub.4 alkyl, q is 0 or 1, and J.sup..crclbar. is a pharmacologically acceptable anion; and the pharmacologically acceptable salts thereof.
- 2. The compound according to claim 1, 5-methyl-3-[[3-[[[[4-(tetradecyloxy)phenyl]amino]carbonyl]amino]phenyl]methyl]thiazolium bromide.
- 3. A pharmaceutical composition of matter in dosage unit form which comprises a compound of claim 1 in association with a pharmaceutically acceptable carrier.
- 4. A method for inhibiting the biological effects of Platelet Activating Factor in a mammal which comprises administering to the mammal a compound of claim 1 in an amount to inhibit Platelet Activating Factor effects.
- 5. A method of treating asthma in a mammal which comprises administering to the mammal an antiasthmatic amount of a compound of claim 1.
- 6. A method for treating anaphylactic and septic shock in a mammal which comprises administering to said mammal an effective amount of a compound of claim 1.
- 7. A method of treating psoriasis in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 8. A method of treating bowel necrosis in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 9. A method of treating adult respiratory distress syndrome in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 10. A method of treating transplant rejection in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 11. A method of treating thrombosis in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 12. A method of treating stroke in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 13. A method of treating cardiac anaphylaxis in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
- 14. A method of treating cancer in a mammal which comprises administering to the mammal an effective amount of a compound of claim 1.
Parent Case Info
This is a divisional of co-pending application Ser. No. 07/868,169, filed on Apr. 14, 1992, now U.S. Pat. No. 5,225,425, which is a divisional of application Ser. No. 07/519,525 filed May 4, 1990, now U.S. Pat. No. 5,128,351.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4692450 |
Cassal |
Sep 1987 |
|
Divisions (2)
|
Number |
Date |
Country |
Parent |
868169 |
Apr 1992 |
|
Parent |
519525 |
May 1990 |
|